Anti-topoisomerase-positive limited systemic sclerosis has a propensity for interstitial lung disease but is linked to favourable prognosis
Rheumatology (Oxford)
.
2022 Nov 28;61(12):4585-4586.
doi: 10.1093/rheumatology/keac287.
Authors
Ruhani P Desai
1
,
Shervin Assassi
1
Affiliation
1
Department of Internal Medicine, Division of Rheumatology, University of Texas Health Science Center at Houston, Houston, TX, USA.
PMID:
35552377
DOI:
10.1093/rheumatology/keac287
No abstract available
Publication types
Editorial
Comment
MeSH terms
Humans
Lung Diseases, Interstitial* / etiology
Prognosis
Scleroderma, Systemic*